Proton Pump Inhibitor Initiation and Withdrawal affects Gut Microbiota and Readmission Risk in Cirrhosis

Intestinal Dysbiosis Secondary to Proton-Pump Inhibitor Use

(2018) Yuji Naito et al.   DIGESTION

Proton Pump Inhibitors Increase Risk for Hepatic Encephalopathy in Patients With Cirrhosis in A Population Study

(2017) Chia-Fen Tsai et al.   GASTROENTEROLOGY

The impact of proton pump inhibitor therapy on patients with liver disease

(2016) H. L. Cole et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Challenge accepted: Confronting readmissions for our patients with cirrhosis

(2016) Elliot B. Tapper   HEPATOLOGY

Proton pump inhibitors as a risk factor for hepatic encephalopathy and spontaneous bacterial peritonitis in patients with cirrhosis with ascites

(2016) Gitte Dam et al.   HEPATOLOGY

The 3-month readmission rate remains unacceptably high in a large North American cohort of patients with cirrhosis

(2016) Jasmohan S. Bajaj et al.   HEPATOLOGY

Impaired Gut-Liver-Brain Axis in Patients with Cirrhosis

(2016) Vishwadeep Ahluwalia et al.   Scientific Reports

Long-term Use of Antibiotics and Proton Pump Inhibitors Predict Development of Infections in Patients With Cirrhosis

(2015) Jacqueline G. O'Leary et al.   Clinical Gastroenterology and Hepatology

Proton Pump Inhibitors Alter Specific Taxa in the Human Gastrointestinal Microbiome: A Crossover Trial

(2015) Daniel E. Freedberg et al.   GASTROENTEROLOGY

Proton pump inhibitors affect the gut microbiome

(2015) Floris Imhann et al.   GUT

Proton pump inhibitors alter the composition of the gut microbiota

(2015) Matthew A Jackson et al.   GUT

Salivary microbiota-immune profiling in cirrhosis: Could this be the noninvasive strategy that will revolutionize prognostication in hepatology?

(2015) Vishal C. Patel et al.   HEPATOLOGY

Salivary microbiota reflects changes in gut microbiota in cirrhosis with hepatic encephalopathy

(2015) Jasmohan S. Bajaj et al.   HEPATOLOGY

Proton pump inhibitor treatment is associated with the severity of liver disease and increased mortality in patients with cirrhosis

(2014) G. Dultz et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Systems biology analysis of omeprazole therapy in cirrhosis demonstrates significant shifts in gut microbiota composition and function

(2014) Jasmohan S. Bajaj et al.   AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY

Alterations of the human gut microbiome in liver cirrhosis

(2014) Nan Qin et al.   NATURE

Altered profile of human gut microbiome is associated with cirrhosis and its complications

(2013) Jasmohan S. Bajaj et al.   JOURNAL OF HEPATOLOGY

Modulation of the Metabiome by Rifaximin in Patients with Cirrhosis and Minimal Hepatic Encephalopathy

(2013) Jasmohan S. Bajaj et al.   PLoS One

Proton pump inhibitors are associated with a high rate of serious infections in veterans with decompensated cirrhosis

(2012) J. S. Bajaj et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Acid-suppressive therapy is associated with spontaneous bacterial peritonitis in cirrhotic patients: A meta-analysis

(2012) Abhishek Deshpande et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Diversity, stability and resilience of the human gut microbiota

(2012) Catherine A. Lozupone et al.   NATURE

Linkage of gut microbiome with cognition in hepatic encephalopathy

(2011) Jasmohan S. Bajaj et al.   AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY

Characterization of fecal microbial communities in patients with liver cirrhosis

(2011) Yanfei Chen et al.   HEPATOLOGY

QIIME allows analysis of high-throughput community sequencing data

(2010) J Gregory Caporaso et al.   NATURE METHODS

Association of Proton Pump Inhibitor Therapy With Spontaneous Bacterial Peritonitis in Cirrhotic Patients With Ascites

(2009) Jasmohan S Bajaj et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Potential Anti-inflammatory Effects of Proton Pump Inhibitors: A Review and Discussion of the Clinical Implications

(2009) Ramalinga R. Kedika et al.   DIGESTIVE DISEASES AND SCIENCES

Microbial community profiling for human microbiome projects: Tools, techniques, and challenges

(2009) M. Hamady et al.   GENOME RESEARCH

Viridans group streptococci causing spontaneous bacterial peritonitis and bacteremia in patients with end-stage liver disease

(2008) Frédéric Bert et al.   LIVER TRANSPLANTATION

Bacterial Infections, Sepsis, and Multiorgan Failure in Cirrhosis

(2008) Puneeta Tandon et al.   SEMINARS IN LIVER DISEASE